Information Provided By:
Fly News Breaks for April 30, 2019
BIOL
Apr 30, 2019 | 09:31 EDT
Dougherty analyst Kyle Bauser initiated Biolase with a Buy and $6 price target telling investors it is a leader in dental lasers and is finding new ways to drive adoption. Bauser said management's turnaround strategy is working and the company is growing its US laser business 50%+ with higher ASPs, and is expected to be EBITDA breakeven in Q4.
News For BIOL From the Last 2 Days
There are no results for your query BIOL